Biblio
Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Biomed Pharmacother. 2022;148:112713.
Trailblazing perspectives on targeting breast cancer stem cells. Pharmacol Ther. 2021:107800.
.